熱門資訊> 正文
管道将更名为CDT Equity
2025-08-05 20:52
- Conduit Pharmaceuticals (NASDAQ:CDT) said on Tuesday that it intends to change its name to CDT Equity reflecting the evolution of its strategy as a data-driven biotech development company.
- Originally established as Conduit Pharmaceuticals, the company has evolved into a broader platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning, the company said.
More on Conduit Pharmaceuticals Inc.
- Financial information for Conduit Pharmaceuticals Inc.
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。